Jan Astermark
71 – 80 of 191
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Strategies for reducing inhibitor formation in severe haemophilia
- Contribution to journal › Scientific review
-
Mark
Non-genetic risk factors and their influence on the management of patients in the clinic
- Contribution to journal › Scientific review
-
Mark
Genetic risk factors for inhibitors in haemophilia A
- Contribution to journal › Scientific review
-
Mark
FVIII inhibitors: pathogenesis and avoidance.
- Contribution to journal › Scientific review
- 2014
-
Mark
A longitudinal study of family structure in Swedish persons with haemophilia.
- Contribution to journal › Article
-
Mark
The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A
- Contribution to journal › Article
-
Mark
Managing Haemophilia for Life: 4th Haemophilia Global Summit
- Contribution to journal › Scientific review
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
- Contribution to journal › Scientific review
-
Mark
A comparison of the treatment of patients with factor IX deficiency to that of those with factor VIII deficiency: results of an International Survey conducted as part of the International FIX Treatment Network.
- Contribution to journal › Letter
-
Mark
Switching clotting factor concentrates: considerations in estimating the risk of immunogenicity
- Contribution to journal › Article